RADICAVA ORS
Live / Registered — Registered (as of 22 Nov 2022)
What this means for you
Registered since 22 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90594021
- Registration number
- 6908091
- Mark type
- Stylized text
- Filed
- 22 Mar 2021
- Published for opposition
- 30 Nov 2021
- Registered
- 22 Nov 2022
- Attorney of record
- Jeffrey Costellia
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Owner
- K.K. BCJ-94, TOKYO, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka, JP
Prior registrations
Prosecution history
- 26 Nov 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Sept 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Sept 2022 — ASSIGNED TO EXAMINER
- 06 Aug 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Jul 2022 — USE AMENDMENT FILED
- 06 Aug 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Jul 2022 — TEAS STATEMENT OF USE RECEIVED
- 25 Jan 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Nov 2021 — PUBLISHED FOR OPPOSITION
- 10 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED